Natco Pharma Limited reported its third quarter earnings for the financial year 2023-24 with profit at Rs 212.70 crore. Natco Pharma Limited on Wednesday reported its third quarter earnings for the ...

Small-cap and large-cap companies receive a lot of attention from investors, but mid-cap stocks like NATCO Pharma Limited (NSE:NATCOPHARM), with a market cap of ₹153.52b, are often out of the ...

The company had posted a consolidated net profit of Rs 212.7 crore in the third quarter of the previous fiscal year, NATCO ...

Natco Pharma plans to acquire South Africa-based Adcock Ingram Holdings, reported CNBC-Awaaz on July 23 citing sources. Adcock Ingram offers generics and OTC medicines in Africa. CNBC-Awaaz reported ...

HOUSTON, July 20 /PRNewswire-FirstCall/ -- NATCO Group Inc. (NYSE: NTG) announced today that it has sold shares representing twenty-five percent ownership in its ...

Yet another Indian drugmaker has had plants written up by the FDA for not hitting manufacturing standards. This time it is Natco Pharma, which said it got Form 483s for its pharmaceutical formulations ...

Shares of Natco Pharma Ltd climbed 18 per cent in Friday's trade to take its four-day rally to 26 per cent. The recent rally on the drug maker was seen as consolidated profit rose multifolds to Rs 212 ...

Shares of Natco Pharma were battered in trade on February 13, plunging as much as 18.5 percent as investors dumped the stock following its disappointing Q3 earnings performance. The drugmaker's net ...

WEST WARWICK, R.I. – Natco Home, a domestic manufacturer of flooring and home décor, has acquired the Orian Rug brand and certain intellectual property rights from parent company SP Orian, LLC. Terms ...

Even as it has filed for a compulsory licence for Covid-19 drug Baricitinib in India, Natco Pharma has already begun rolling out its generic version of the rheumatoid arthritis drug under the Barinat ...